2023
DOI: 10.1001/jama.2023.5302
|View full text |Cite
|
Sign up to set email alerts
|

Prednisone vs Placebo and Live Birth in Patients With Recurrent Implantation Failure Undergoing In Vitro Fertilization

Abstract: ImportanceImplantation failure remains a critical barrier to in vitro fertilization. Prednisone, as an immune-regulatory agent, is widely used to improve the probability of implantation and pregnancy, although the evidence for efficacy is inadequate.ObjectiveTo determine the efficacy of 10 mg of prednisone compared with placebo on live birth among women with recurrent implantation failure.Design, Setting, and ParticipantsA double-blind, placebo-controlled, randomized clinical trial conducted at 8 fertility cen… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
15
1

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 18 publications
(16 citation statements)
references
References 38 publications
0
15
1
Order By: Relevance
“…In contrast, the recent JAMA article defined autoimmune disease as the only immune exclusion criterion in their study . The authors did not evaluate endometrial or systemic immune biomarkers to better select participants.…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…In contrast, the recent JAMA article defined autoimmune disease as the only immune exclusion criterion in their study . The authors did not evaluate endometrial or systemic immune biomarkers to better select participants.…”
mentioning
confidence: 99%
“…To the Editor We have some concerns about the recent study that evaluated the effect of prednisone on the live birth rate in patients with recurrent implantation failure (RIF). Immunosuppressive therapies for patients with reproductive failures (recurrent miscarriage and RIF) remain controversial, despite the fact that the European Society of Human Reproduction and Embryology recently declared intravenous immunoglobulin to be capable of improving pregnancy outcomes in individuals with recurrent miscarriage .…”
mentioning
confidence: 99%
“…To the Editor A recent study did not report a benefit with use of prednisone in patients with RIF undergoing in vitro fertilization . Although some studies support corticosteroid use in patients with RIF, prednisone is not an approved drug to be used for this condition .…”
mentioning
confidence: 99%
“…We have questions about certain points of this study . First, the article stated that the patients were administered prednisone, 10 mg once daily, until 12 weeks of gestation.…”
mentioning
confidence: 99%
See 1 more Smart Citation